Request for Covid-19 Impact Assessment of this Report
The United States Nasal Decongestant market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nasal Decongestant market, reaching US$ million by the year 2028. As for the Europe Nasal Decongestant landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Nasal Decongestant players cover Abbott Laboratories, Glaxosmithkline, Cipla, and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Nasal Decongestant market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Nasal Strips
Tablet
Spray
Capsule
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Asthma
Cold
Nasal Allergies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Abbott Laboratories
Glaxosmithkline
Cipla
Bayer
ADAPT Pharma
Patrick Parsons
Nidda Healthcare
Procter and Gamble
Rugby Laboratories
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nasal Decongestant Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Nasal Decongestant by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Nasal Decongestant by Country/Region, 2017, 2022 & 2028
2.2 Nasal Decongestant Segment by Type
2.2.1 Nasal Strips
2.2.2 Tablet
2.2.3 Spray
2.2.4 Capsule
2.3 Nasal Decongestant Sales by Type
2.3.1 Global Nasal Decongestant Sales Market Share by Type (2017-2022)
2.3.2 Global Nasal Decongestant Revenue and Market Share by Type (2017-2022)
2.3.3 Global Nasal Decongestant Sale Price by Type (2017-2022)
2.4 Nasal Decongestant Segment by Application
2.4.1 Asthma
2.4.2 Cold
2.4.3 Nasal Allergies
2.5 Nasal Decongestant Sales by Application
2.5.1 Global Nasal Decongestant Sale Market Share by Application (2017-2022)
2.5.2 Global Nasal Decongestant Revenue and Market Share by Application (2017-2022)
2.5.3 Global Nasal Decongestant Sale Price by Application (2017-2022)
3 Global Nasal Decongestant by Company
3.1 Global Nasal Decongestant Breakdown Data by Company
3.1.1 Global Nasal Decongestant Annual Sales by Company (2020-2022)
3.1.2 Global Nasal Decongestant Sales Market Share by Company (2020-2022)
3.2 Global Nasal Decongestant Annual Revenue by Company (2020-2022)
3.2.1 Global Nasal Decongestant Revenue by Company (2020-2022)
3.2.2 Global Nasal Decongestant Revenue Market Share by Company (2020-2022)
3.3 Global Nasal Decongestant Sale Price by Company
3.4 Key Manufacturers Nasal Decongestant Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nasal Decongestant Product Location Distribution
3.4.2 Players Nasal Decongestant Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nasal Decongestant by Geographic Region
4.1 World Historic Nasal Decongestant Market Size by Geographic Region (2017-2022)
4.1.1 Global Nasal Decongestant Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Nasal Decongestant Annual Revenue by Geographic Region
4.2 World Historic Nasal Decongestant Market Size by Country/Region (2017-2022)
4.2.1 Global Nasal Decongestant Annual Sales by Country/Region (2017-2022)
4.2.2 Global Nasal Decongestant Annual Revenue by Country/Region
4.3 Americas Nasal Decongestant Sales Growth
4.4 APAC Nasal Decongestant Sales Growth
4.5 Europe Nasal Decongestant Sales Growth
4.6 Middle East & Africa Nasal Decongestant Sales Growth
5 Americas
5.1 Americas Nasal Decongestant Sales by Country
5.1.1 Americas Nasal Decongestant Sales by Country (2017-2022)
5.1.2 Americas Nasal Decongestant Revenue by Country (2017-2022)
5.2 Americas Nasal Decongestant Sales by Type
5.3 Americas Nasal Decongestant Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nasal Decongestant Sales by Region
6.1.1 APAC Nasal Decongestant Sales by Region (2017-2022)
6.1.2 APAC Nasal Decongestant Revenue by Region (2017-2022)
6.2 APAC Nasal Decongestant Sales by Type
6.3 APAC Nasal Decongestant Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nasal Decongestant by Country
7.1.1 Europe Nasal Decongestant Sales by Country (2017-2022)
7.1.2 Europe Nasal Decongestant Revenue by Country (2017-2022)
7.2 Europe Nasal Decongestant Sales by Type
7.3 Europe Nasal Decongestant Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nasal Decongestant by Country
8.1.1 Middle East & Africa Nasal Decongestant Sales by Country (2017-2022)
8.1.2 Middle East & Africa Nasal Decongestant Revenue by Country (2017-2022)
8.2 Middle East & Africa Nasal Decongestant Sales by Type
8.3 Middle East & Africa Nasal Decongestant Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nasal Decongestant
10.3 Manufacturing Process Analysis of Nasal Decongestant
10.4 Industry Chain Structure of Nasal Decongestant
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nasal Decongestant Distributors
11.3 Nasal Decongestant Customer
12 World Forecast Review for Nasal Decongestant by Geographic Region
12.1 Global Nasal Decongestant Market Size Forecast by Region
12.1.1 Global Nasal Decongestant Forecast by Region (2023-2028)
12.1.2 Global Nasal Decongestant Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nasal Decongestant Forecast by Type
12.7 Global Nasal Decongestant Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Nasal Decongestant Product Offered
13.1.3 Abbott Laboratories Nasal Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 Glaxosmithkline
13.2.1 Glaxosmithkline Company Information
13.2.2 Glaxosmithkline Nasal Decongestant Product Offered
13.2.3 Glaxosmithkline Nasal Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Glaxosmithkline Main Business Overview
13.2.5 Glaxosmithkline Latest Developments
13.3 Cipla
13.3.1 Cipla Company Information
13.3.2 Cipla Nasal Decongestant Product Offered
13.3.3 Cipla Nasal Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Cipla Main Business Overview
13.3.5 Cipla Latest Developments
13.4 Bayer
13.4.1 Bayer Company Information
13.4.2 Bayer Nasal Decongestant Product Offered
13.4.3 Bayer Nasal Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bayer Main Business Overview
13.4.5 Bayer Latest Developments
13.5 ADAPT Pharma
13.5.1 ADAPT Pharma Company Information
13.5.2 ADAPT Pharma Nasal Decongestant Product Offered
13.5.3 ADAPT Pharma Nasal Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 ADAPT Pharma Main Business Overview
13.5.5 ADAPT Pharma Latest Developments
13.6 Patrick Parsons
13.6.1 Patrick Parsons Company Information
13.6.2 Patrick Parsons Nasal Decongestant Product Offered
13.6.3 Patrick Parsons Nasal Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Patrick Parsons Main Business Overview
13.6.5 Patrick Parsons Latest Developments
13.7 Nidda Healthcare
13.7.1 Nidda Healthcare Company Information
13.7.2 Nidda Healthcare Nasal Decongestant Product Offered
13.7.3 Nidda Healthcare Nasal Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Nidda Healthcare Main Business Overview
13.7.5 Nidda Healthcare Latest Developments
13.8 Procter and Gamble
13.8.1 Procter and Gamble Company Information
13.8.2 Procter and Gamble Nasal Decongestant Product Offered
13.8.3 Procter and Gamble Nasal Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Procter and Gamble Main Business Overview
13.8.5 Procter and Gamble Latest Developments
13.9 Rugby Laboratories
13.9.1 Rugby Laboratories Company Information
13.9.2 Rugby Laboratories Nasal Decongestant Product Offered
13.9.3 Rugby Laboratories Nasal Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Rugby Laboratories Main Business Overview
13.9.5 Rugby Laboratories Latest Developments
14 Research Findings and Conclusion
Table 1. Nasal Decongestant Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Nasal Decongestant Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Nasal Strips
Table 4. Major Players of Tablet
Table 5. Major Players of Spray
Table 6. Major Players of Capsule
Table 7. Global Nasal Decongestant Sales by Type (2017-2022) & (K Units)
Table 8. Global Nasal Decongestant Sales Market Share by Type (2017-2022)
Table 9. Global Nasal Decongestant Revenue by Type (2017-2022) & ($ million)
Table 10. Global Nasal Decongestant Revenue Market Share by Type (2017-2022)
Table 11. Global Nasal Decongestant Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Nasal Decongestant Sales by Application (2017-2022) & (K Units)
Table 13. Global Nasal Decongestant Sales Market Share by Application (2017-2022)
Table 14. Global Nasal Decongestant Revenue by Application (2017-2022)
Table 15. Global Nasal Decongestant Revenue Market Share by Application (2017-2022)
Table 16. Global Nasal Decongestant Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Nasal Decongestant Sales by Company (2020-2022) & (K Units)
Table 18. Global Nasal Decongestant Sales Market Share by Company (2020-2022)
Table 19. Global Nasal Decongestant Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Nasal Decongestant Revenue Market Share by Company (2020-2022)
Table 21. Global Nasal Decongestant Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Nasal Decongestant Producing Area Distribution and Sales Area
Table 23. Players Nasal Decongestant Products Offered
Table 24. Nasal Decongestant Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Nasal Decongestant Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Nasal Decongestant Sales Market Share Geographic Region (2017-2022)
Table 29. Global Nasal Decongestant Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Nasal Decongestant Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Nasal Decongestant Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Nasal Decongestant Sales Market Share by Country/Region (2017-2022)
Table 33. Global Nasal Decongestant Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Nasal Decongestant Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Nasal Decongestant Sales by Country (2017-2022) & (K Units)
Table 36. Americas Nasal Decongestant Sales Market Share by Country (2017-2022)
Table 37. Americas Nasal Decongestant Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Nasal Decongestant Revenue Market Share by Country (2017-2022)
Table 39. Americas Nasal Decongestant Sales by Type (2017-2022) & (K Units)
Table 40. Americas Nasal Decongestant Sales Market Share by Type (2017-2022)
Table 41. Americas Nasal Decongestant Sales by Application (2017-2022) & (K Units)
Table 42. Americas Nasal Decongestant Sales Market Share by Application (2017-2022)
Table 43. APAC Nasal Decongestant Sales by Region (2017-2022) & (K Units)
Table 44. APAC Nasal Decongestant Sales Market Share by Region (2017-2022)
Table 45. APAC Nasal Decongestant Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Nasal Decongestant Revenue Market Share by Region (2017-2022)
Table 47. APAC Nasal Decongestant Sales by Type (2017-2022) & (K Units)
Table 48. APAC Nasal Decongestant Sales Market Share by Type (2017-2022)
Table 49. APAC Nasal Decongestant Sales by Application (2017-2022) & (K Units)
Table 50. APAC Nasal Decongestant Sales Market Share by Application (2017-2022)
Table 51. Europe Nasal Decongestant Sales by Country (2017-2022) & (K Units)
Table 52. Europe Nasal Decongestant Sales Market Share by Country (2017-2022)
Table 53. Europe Nasal Decongestant Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Nasal Decongestant Revenue Market Share by Country (2017-2022)
Table 55. Europe Nasal Decongestant Sales by Type (2017-2022) & (K Units)
Table 56. Europe Nasal Decongestant Sales Market Share by Type (2017-2022)
Table 57. Europe Nasal Decongestant Sales by Application (2017-2022) & (K Units)
Table 58. Europe Nasal Decongestant Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Nasal Decongestant Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Nasal Decongestant Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Nasal Decongestant Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Nasal Decongestant Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Nasal Decongestant Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Nasal Decongestant Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Nasal Decongestant Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Nasal Decongestant Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Nasal Decongestant
Table 68. Key Market Challenges & Risks of Nasal Decongestant
Table 69. Key Industry Trends of Nasal Decongestant
Table 70. Nasal Decongestant Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Nasal Decongestant Distributors List
Table 73. Nasal Decongestant Customer List
Table 74. Global Nasal Decongestant Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Nasal Decongestant Sales Market Forecast by Region
Table 76. Global Nasal Decongestant Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Nasal Decongestant Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Nasal Decongestant Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Nasal Decongestant Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Nasal Decongestant Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Nasal Decongestant Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Nasal Decongestant Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Nasal Decongestant Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Nasal Decongestant Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Nasal Decongestant Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Nasal Decongestant Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Nasal Decongestant Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Nasal Decongestant Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Nasal Decongestant Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Nasal Decongestant Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Nasal Decongestant Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Nasal Decongestant Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Nasal Decongestant Revenue Market Share Forecast by Application (2023-2028)
Table 94. Abbott Laboratories Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 95. Abbott Laboratories Nasal Decongestant Product Offered
Table 96. Abbott Laboratories Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Abbott Laboratories Main Business
Table 98. Abbott Laboratories Latest Developments
Table 99. Glaxosmithkline Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 100. Glaxosmithkline Nasal Decongestant Product Offered
Table 101. Glaxosmithkline Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Glaxosmithkline Main Business
Table 103. Glaxosmithkline Latest Developments
Table 104. Cipla Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 105. Cipla Nasal Decongestant Product Offered
Table 106. Cipla Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Cipla Main Business
Table 108. Cipla Latest Developments
Table 109. Bayer Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 110. Bayer Nasal Decongestant Product Offered
Table 111. Bayer Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Bayer Main Business
Table 113. Bayer Latest Developments
Table 114. ADAPT Pharma Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 115. ADAPT Pharma Nasal Decongestant Product Offered
Table 116. ADAPT Pharma Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. ADAPT Pharma Main Business
Table 118. ADAPT Pharma Latest Developments
Table 119. Patrick Parsons Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 120. Patrick Parsons Nasal Decongestant Product Offered
Table 121. Patrick Parsons Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Patrick Parsons Main Business
Table 123. Patrick Parsons Latest Developments
Table 124. Nidda Healthcare Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 125. Nidda Healthcare Nasal Decongestant Product Offered
Table 126. Nidda Healthcare Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Nidda Healthcare Main Business
Table 128. Nidda Healthcare Latest Developments
Table 129. Procter and Gamble Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 130. Procter and Gamble Nasal Decongestant Product Offered
Table 131. Procter and Gamble Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Procter and Gamble Main Business
Table 133. Procter and Gamble Latest Developments
Table 134. Rugby Laboratories Basic Information, Nasal Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 135. Rugby Laboratories Nasal Decongestant Product Offered
Table 136. Rugby Laboratories Nasal Decongestant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Rugby Laboratories Main Business
Table 138. Rugby Laboratories Latest Developments
List of Figures
Figure 1. Picture of Nasal Decongestant
Figure 2. Nasal Decongestant Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nasal Decongestant Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Nasal Decongestant Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Nasal Decongestant Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Nasal Strips
Figure 10. Product Picture of Tablet
Figure 11. Product Picture of Spray
Figure 12. Product Picture of Capsule
Figure 13. Global Nasal Decongestant Sales Market Share by Type in 2021
Figure 14. Global Nasal Decongestant Revenue Market Share by Type (2017-2022)
Figure 15. Nasal Decongestant Consumed in Asthma
Figure 16. Global Nasal Decongestant Market: Asthma (2017-2022) & (K Units)
Figure 17. Nasal Decongestant Consumed in Cold
Figure 18. Global Nasal Decongestant Market: Cold (2017-2022) & (K Units)
Figure 19. Nasal Decongestant Consumed in Nasal Allergies
Figure 20. Global Nasal Decongestant Market: Nasal Allergies (2017-2022) & (K Units)
Figure 21. Global Nasal Decongestant Sales Market Share by Application (2017-2022)
Figure 22. Global Nasal Decongestant Revenue Market Share by Application in 2021
Figure 23. Nasal Decongestant Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Nasal Decongestant Revenue Market Share by Company in 2021
Figure 25. Global Nasal Decongestant Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Nasal Decongestant Revenue Market Share by Geographic Region in 2021
Figure 27. Global Nasal Decongestant Sales Market Share by Region (2017-2022)
Figure 28. Global Nasal Decongestant Revenue Market Share by Country/Region in 2021
Figure 29. Americas Nasal Decongestant Sales 2017-2022 (K Units)
Figure 30. Americas Nasal Decongestant Revenue 2017-2022 ($ Millions)
Figure 31. APAC Nasal Decongestant Sales 2017-2022 (K Units)
Figure 32. APAC Nasal Decongestant Revenue 2017-2022 ($ Millions)
Figure 33. Europe Nasal Decongestant Sales 2017-2022 (K Units)
Figure 34. Europe Nasal Decongestant Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Nasal Decongestant Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Nasal Decongestant Revenue 2017-2022 ($ Millions)
Figure 37. Americas Nasal Decongestant Sales Market Share by Country in 2021
Figure 38. Americas Nasal Decongestant Revenue Market Share by Country in 2021
Figure 39. United States Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Nasal Decongestant Sales Market Share by Region in 2021
Figure 44. APAC Nasal Decongestant Revenue Market Share by Regions in 2021
Figure 45. China Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Nasal Decongestant Sales Market Share by Country in 2021
Figure 52. Europe Nasal Decongestant Revenue Market Share by Country in 2021
Figure 53. Germany Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Nasal Decongestant Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Nasal Decongestant Revenue Market Share by Country in 2021
Figure 60. Egypt Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Nasal Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Nasal Decongestant in 2021
Figure 66. Manufacturing Process Analysis of Nasal Decongestant
Figure 67. Industry Chain Structure of Nasal Decongestant
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...